Cardiac CT

Cardiac CT

  • Purpose: To obtain detailed 3D images of the heart and surrounding structures.

  • Cardiac CT vs. CT Coronary Arteries (CTCA):

    • CTCA is used for symptomatic patients suspected of having Coronary Artery Disease (CAD).
    • A good negative score on CTCA indicates a low risk for CAD.
  • CTCA Includes:

    • Calcium Score
    • Imaging of Valves & Heart Chambers
    • Congenital Pathologies
    • Pre/Post Surgery Assessment

Normal Cardiac Anatomy

  • RA – Right Atrium

  • RV – Right Ventricle

  • LA – Left Atrium

  • LV – Left Ventricle

  • Ao – Aorta/Aortic Root

  • N – Non-coronary Cusp

  • R – Right Coronary Cusp

  • L – Left Coronary Cusp

  • LM – Left Main

  • LAD – Left Anterior Descending

  • CX – Circumflex

  • RCA – Right Coronary Artery

Abnormal Cardiac Anatomy and Pathologies

  • Coronary Artery Disease (CAD):

    • Damage or disease in the heart's major blood vessels.
    • Buildup of fats and cholesterol on artery walls, leading to narrowing and reduced blood flow.
    • Symptoms: Chest pain (Angina), Shortness of Breath (SOB), Fatigue.
  • Grading of Artery Stenosis:

    • 90% stenosis means 10% of the artery is open.
    • 10% stenosis means 90% of the artery is open.
  • Congenital Pathologies:

    • Aortic Valve Stenosis: Narrowing of the aortic valve.
    • Patent Ductus Arteriosus: Extra blood in the lungs, leading to increased right heart pressure.
    • Septal Defects: Atrial or Ventricular, causing decreased or increased heart pressure.
    • Tetralogy of Fallot: A combination of heart defects, leading to complications in growth and development, heart failure, and pulmonary hypertension.

Indications and Screening for CTCA

  • Indications:

    • CTCA is primarily used for patients with suspected coronary artery disease who have a low or intermediate risk.
    • Low-risk patients: Symptoms suggestive of coronary artery disease, normal ECG, normal cardiac enzyme tests, and no risk factors for coronary artery disease.
    • Intermediate-risk patients: Similar symptoms, negative ECG and cardiac enzymes, but with risk factors for coronary artery disease.
    • Examples of risk factors: Chest Pain on Exertion, SOB, Family History, High Cholesterol.
  • Pre-requisites for CTCA:

    • Non-Acute Investigation of Chest Pain/Pathology: CTCA is usually not performed on acute patients who are more likely to undergo invasive coronary angiography.
      • No elevation of serum markers indicating cardiac damage (Troponin, Creatine Kinase-MB, Myoglobin, Lactase Dehydrogenase).
      • No ECG changes of acute cardiac ischemia (ST-Segment Elevation, T-Wave Changes, Reciprocal/Depression, Arrhythmias).
      • No Renal Failure: eGFR < 30mL/min indicates acute presentations.
      • No Pregnancy due to radiation and contrast exposure.
  • Screening Patient Pathway:

    • Diagnostic algorithm for patients with possible ischemic heart disease:
      • Run tests:
        • Normal: No further action needed.
        • Indicative of heart disease: Referred to cardiologist.
        • Equivocal: Needs further investigation.
      • Further investigation:
        • Normal: No further action needed.
        • Indicative of heart disease: Referred to cardiologist.
        • Equivocal: CTCA is performed.

Patient Preparation for Cardiac CT

  • Heart Rate:

    • High heart rates decrease diagnostic accuracy.
    • Ideal HR: <60/65 bpm
    • Elevated HR: 60/65-80 bpm
    • High HR: >80 bpm
  • Medications to slow HR:

    • No Stimulants for 12 hours prior (Caffeine, Alcohol, Tobacco, Exercise).
    • β-Blockers: Necessary if HR on breath-hold is >65 bpm or irregular.
      • Oral Beta Blockers (Metoprolol or Ivabradine): Prescribed by requesting Doctor or Radiologist.
        • Radiologist Dose: 50mg tablet taken 1 hour prior to scan.
      • IV Beta Blockers: Independent or Supplementary to Oral β-B.
        • Administered on the table.
        • Dose: up to 15mg IV delivered in 2.5mg titration.
  • Vasodilators:

    • Improve image quality and diagnostic accuracy by relaxing vessel walls and increasing vessel diameter.
    • Increases the number of coronary segments able to be assessed by CTCA.
    • Medications: GTN (Glyceryl Trinitrate) administered via 2 sprays sublingually.
    • Contraindications:
      • Viagra/Cialis within 72 hours.
      • Patients with low blood pressure.
    • Side Effects:
      • May result in increased HR.
      • Can cause blood pressure to decrease.
      • Light-headedness/headache.

Calcium Score vs. CT Coronary Angiograms

  • CT CALCIUM SCORING:

    • Quantitative assessment of coronary artery lesions.
    • Detects hard plaques only (no soft plaques).
    • Determines total plaque burden, indicating the risk of a cardiac event.
    • Performed independently or with CTCA.
    • Risk stratification for women (35-70yrs) and men (40-60yrs). Generally accepted that 40yrs is the minimum.
    • Matched against similar age, sex, population (MESA).
    • Who is it for? Low risk and intermediate risk patients.
  • Patient Prep for Calcium Scoring:

    • Prior to Arrival:
      • No caffeine, alcohol, cigarettes, exercise 12 hours prior.
      • No fasting required.
      • No withholding of medications.
    • Prior to Scan:
      • Clothing above the waist removed.
      • Gown open at the front.
    • On Table:
      • ECG Leads on patient.
      • Non-contrast.
      • Medium breath hold (excessive breath hold increases HR).
      • Agatston method
  • Technique for Calcium Scoring:

    • AP Topogram
    • Scan range to cover coronary vessels (carina → coronary arteries).
    • 120kVp
    • Tube current per patient.
    • 3mm contiguous slices.
  • Post Processing for Calcium Scoring:

    • Auto/Manual ‘tagging’ of hard plaques (Synago, Vitrea).
    • Calculations, based on:
      • Individual lesions (area of calcification multiplied by weighted density score given to the highest attenuation value (HU) in the lesion; higher density = greater weighting factor).
      • Total score (sum of all lesions).
  • RESULTS of Calcium Scoring:

    • CA score 1-100 → low risk → <10% chance of having MI/stroke in the next 10 years.
    • CA score >400 → high risk → >20% chance of MI/stroke in the next 10 years.
    • Can be used to guide treatment options (e.g. individualised statin/lifestyle regime).

Post Processing Techniques

  • Auto/manual ‘tagging’ of hard plaques:
    • Syngo (via SIEMENS)
    • Vitrea (via Cannon)

Non-Coronary Artery Procedures

  • Bypass Grafts:

    • Monitoring post bypass graft surgery (Post Coronary Artery Bypass Grafts - CABG).
    • Patient preparation is identical to CTCA.
    • No calcium score required.
    • Extended range:
      • Dependent on graft types (Common for LIMA (Left Internal Mammory Artery) + SVG (Scalable Vector Graphics)).
      • Subclavian to below heart
    • Larger bolus: 70-80ml contrast/50ml saline.
    • Test bolus & Scan Delay: Additional delay to allow for grafts to fill
    • Prospective gating
      • High Pitch Spiral
    • Consider higher kVp
      • Excessive plaque burden
      • Large BMI
  • Transcatheter Aortic Valve Implantation (TAVI):

    • Pre-Surgery Planning + Post Surgery Eval.
    • Patient Preparation Similar to CTCA:
      • No GTN and No β-B given.
    • AP and Lateral Full Length Topograms
    • Contrast Bolus:
      • No test bolus
      • Bolus tracking in Asc. Aorta @ 100HU100 HU
      • 90ml90ml contrast/50ml50ml saline @ 6ml/s6ml/s
    • Imaging:
      • Ca Score of Aortic Valve
      • Retrospective gated Spiral/Helical Scan of Aortic Valve
      • Lower 1/3 of heart to carina
      • High Pitch helical Aorta
      • Mid carotids to below pubic symph.
  • Left Atrium:

    • Indications:
      • Pulmonary Vein Isolation (PVI)
      • Left Atrial Appendage (LAA) Closure
    • Patient Preparation Similar to CTCA
      • No GTN and No β-B given.
    • AP Topogram
    • Contrast Bolus:
      • Test Bolus (in left atrium)
        • 10ml10ml contrast/30ml30ml saline @ 6ml/s6ml/s
      • Scan
        • 60ml60ml contrast/50ml50ml saline @ 6ml/s6 ml/s
        • Consider 70ml70ml @ 7ml/s7ml/s for large patient
    • Imaging:
      • Prospective
      • Arterial
        • Above Carina to Lower 1/3 of heart
        • Entire left atrium and Pulmonary Veins
      • Delayed Arterial
        • Top of heart/Pulmonary artery trunk to inferior to atrial appendage/mid heart
        • To cover left atrial appendage only
  • Shunting/Congenital

    • Indications
      • Patent Foramen Ovale (PFO)
    • Patient Preparation Similar to CTCA
      • No GTN and No β-B given.
    • AP Topogram
    • Contrast Bolus:
      • Test Bolus or bolus tracking
      • Scan
        • 70ml70ml contrast/50ml50ml saline @ 6ml/s6 ml/s
        • Consider 80ml80ml @ 7ml/s7ml/s for large patient
    • Imaging:
      • Prospective Gating
      • Non-Contrast as required
      • Arterial
        • Whole heart or Region of Interest
      • Delayed Arterial as required
        • Region of interest

Routine Protocols in CT Cardiac Examinations

  • Pre-Exam Observations:
    • Resting HR, BP, medication Hx
  • Patient Cannulated
  • Patient Changed:
    • Clothing above waist removed
    • Patient gown open at front (ECG leads placed on chest)
  • Patient Supine Feet-first
  • ECG Leads Connected
  • HR stabilised and optimal for scan
  • GTN Given
  • AP Topogram
  • +/- Calcium Score
  • Contrast Test bolus
    • 10ml10ml contrast/50ml50ml saline @ 6ml/s6ml/s
  • Scan Technique selected based on HR
    • <60/65 bpm = Prospective Gating
      • High pitch helical/Large Volume
    • 60/65-80bpm = Prospective Gating
      • Sequential
    • >80bpm = Retrospective Gating
      • Spiral/Helical (multiple cardiac cycles)
  • kVp
    • Low for normal vessels
    • Increase for excessive hard plaques or large BMI
  • mA
    • Dose modulation to improve patient dose
  • Scan Range
    • Above coronary arteries to below heart